Takaya Nakane

Takaya Nakane

University of Yamanashi, Kōfu, Yamanashi, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2013 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
TNTakaya Nakane
Takaya Nakane
NKNakamura Kousuke
Nakamura Kousuke
HSHata Sonoko
Hata Sonoko
KYKamiya Yuko
Kamiya Yuko
HSHidenori Sato
Hidenori Sato
KSKanji Sugita
Kanji Sugita

18 October 2011 in Molecular Syndromology
Verified
Journal Article
Open access
PDF file
TNTakaya Nakane
Takaya Nakane
TTT. Tando
T. Tando
KAK. Aoyagi
K. Aoyagi
KHK. Hatakeyama
K. Hatakeyama
GNG. Nishimura
G. Nishimura
KSK. Sugita
K. Sugita
Dysspondyloenchondromatosis (DSC) is a rare skeletal dysplasia that has currently been classified into the group of spondylometaphyseal dysplasias. To date, only 12 affected individuals have been reported. All cases are sporadic, and the etiology remains unknown. Distinctive features of DSC are anisospondyly and enchondroma-like lesions in the metaphyseal and diaphyseal portions of the long tubular bones. Affected individuals usually develop kyphoscoliosis and asymmetric limb shortening at an early age. Interestingly, some of the skeletal changes overlap with spondyloepimetaphyseal dysplasia (SEMD) Strudwick type, a rare type II collagen disorder. Based on this resemblance we postulated that DSC may be allelic to SEMD Strudwick type and therefore performed a COL2A1 analysis in an affected boy who was diagnosed as having DSC at the age of 3 years. The identification of a novel heterozygous COL2A1 missense mutation (p.Gly753Asp) in the proband confirms our hypothesis and suggests that DSC may be another type II collagen disorder.

10 April 2023 in Children
Verified
Journal Article
Open access
PDF file
FSFumikazu Sano
Fumikazu Sano
TFToshimichi Fukao
Toshimichi Fukao
HYHideaki Yagasaki
Hideaki Yagasaki
HKHideaki Kanemura
Hideaki Kanemura
TITakeshi Inukai
Takeshi Inukai
TNTakaya Nakane
Takaya Nakane
Heterozygous variants in the ATP1A3 gene are linked to well-known neurological phenotypes. There has been growing evidence for a separate phenotype associated with variants in residue Arg756—fever-induced paroxysmal weakness and encephalopathy (FIPWE) or relapsing encephalopathy with cerebellar ataxia (RECA). With only about 20 cases being reported, the clinical features associated with mutations at Arg756 have not been fully elucidated. We report a case of FIPWE with a p.Arg756Cys change in the ATP1A3 gene and a comparison of the clinical features, including electrophysiological examination, with previous cases. The 3-year-old male patient had normal psychomotor development, presenting with recurrent symptoms of generalized hypotonia with loss of gait, mutism, and dystonic movements only during febrile illnesses since 19 months of age. At 2.7 years of age, a third neurological decompensation episode occurred, during which electroencephalography (EEG) did not reveal high voltage slow waves or epileptiform discharge. Nerve conduction studies (NCS) also did not show latency delay or amplitude reduction. ATP1A3 exon sequencing showed a heterozygous p.Arg756Cys mutation. While the patient experienced repeated encephalopathy-like episodes, including severe hypotonia during febrile illness, EEG and NCS did not reveal any obvious abnormalities. These electrophysiological findings may represent an opportunity to suspect FIPWE and RECA.

1 July 2010
Verified
Journal Article
Closed access
SNSayaka Noguchi
Sayaka Noguchi
YKYoshimi Kaga
Yoshimi Kaga
YTYukitoshi Takahashi
Yukitoshi Takahashi
KAKakuro Aoyagi
Kakuro Aoyagi
KNKohsuke Nakamura
Kohsuke Nakamura
MAMasao Aihara
Masao Aihara

1 January 2012 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
TNTakaya Nakane
Takaya Nakane
KHKohsuke Higashida
Kohsuke Higashida
KSKanji Sugita
Kanji Sugita
We describe here a Japanese male infant who transiently showed a marked elevation of midregion parathyroid hormone (M-PTH) fragments in serum with no increase in full-length 1-84 amino acid PTH and carboxy-terminal PTH fragments. He presented with a large anterior fontanel, delayed closure of the anterior fontanel, and mild short stature at 4 months old; he was normocalcemic with a normal urine calcium/creatinine ratio and absent subperiosteal bone resorption on X-ray film. Serum levels of M-PTH fragments were in >3200 pg/mL but logarithmically decreased with age. Our case report demonstrates that M-PTH fragments have no effect on calcium release from bones in humans.